Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Electrocardiogram st-t segment abnormal? 9 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Electrocardiogram st-t segment abnormal have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.0% of all adverse event reports for ATORVASTATIN.

9
Reports of Electrocardiogram st-t segment abnormal with ATORVASTATIN
0.0%
of all ATORVASTATIN reports
0
Deaths
1
Hospitalizations

How Dangerous Is Electrocardiogram st-t segment abnormal From ATORVASTATIN?

Of the 9 reports, 1 (11.1%) required hospitalization.

Is Electrocardiogram st-t segment abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Electrocardiogram st-t segment abnormal?

VENLAFAXINE (26) LEVOTHYROXINE (24) CLOZAPINE (22) AMLODIPINE (13) FLUOROURACIL (13) PIPAMPERONE (12) BISOPROLOL (11) DIENOGEST\ETHINYL ESTRADIOL (11) MESALAMINE (11) OXALIPLATIN (11)

Which ATORVASTATIN Alternatives Have Lower Electrocardiogram st-t segment abnormal Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Electrocardiogram st-t segment abnormal Reports All Drugs Causing Electrocardiogram st-t segment abnormal ATORVASTATIN Demographics